Legal Opinion
Biotechnology Industry Organization v. District of Columbia
Court of Appeals for the Federal Circuit
Decided August 1, 2007No. 2006-1593PublishedCited by 40 opinions
1Opinion of the Court
GAJARSA, Circuit Judge.
This is a pre-enforcement challenge to a statute of the District of Columbia, before this court after transfer from the United States Court of Appeals for the District of Columbia Circuit. Defendants, the District of Columbia and various of its departments and officers (collectively, “the District” or “D.C.”), appeal from a judgment of the United States District Court for the District of Columbia declaring the District’s Prescription Drug Excessive Pricing Act of 2005, codified at D.C.Code § 28-4551 to 28-4555 (“the Act”), preempted by the federal patent laws and…
2Cases cited36 opinions
- Lujan v. Defenders of WildlifeSupreme Court of the United States · 1992
- Warth v. SeldinSupreme Court of the United States · 1975
- Friends of the Earth, Inc. v. Laidlaw Environmental Services (TOC), Inc.Supreme Court of the United States · 2000
- Franchise Tax Bd. of Cal. v. Construction Laborers Vacation Trust for Southern Cal.Supreme Court of the United States · 1983
- Hunt v. Washington State Apple Advertising CommissionSupreme Court of the United States · 1977
31 more not listed; retrieve them via the Exa API.
3Cited by40 opinions
- Dominant Semiconductors Sdn. Bhd. v. Osram GmbHCourt of Appeals for the Federal Circuit · 2008
- State of Vermont v. Mphj Technology InvestmentsCourt of Appeals for the Federal Circuit · 2015
- Southeastern Pennsylvania Transportation Authority v. Gilead Sciences, Inc.District Court, E.D. Pennsylvania · 2015
- In re EpipenDistrict Court, D. Kansas · 2018
- St. Louis Ass'n of Realtors v. City of FergusonSupreme Court of Missouri · 2011
35 more not listed; retrieve them via the Exa API.